Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Authors : Paulus Kirchhof; Gregory Y.H. Lip; Isabelle C. Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kaab; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Axel Brandes; Michael Ezekowitz; Hans Diener; Laurent Haegeli1; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Maria Aunes-Jansson; Carina Blomstrom-Lundqvist; Maria Borentain; Stefanie Breitenstein; Martina Brueckmann; Nilo Cater; Andreas Clemens; Dobromir Dobrev Sergio Dubner; Nils G. Edvardsson18; Leif Friberg; Andreas Goette; Michele Gulizia; Robert Hatala; Jenny Horwood; Lukas Szumowski; Lukas Kappenberger; Josef Kautzner; Angelika Leute; Trudie Lobban; Ralf Meyer; Jay Millerhagen; John Morgan; Felix Muenzel; Michael Nabauer; Christoph Baertels; Michael Oeff; Dieter Paar; Juergen Polifka; Ursula Ravens; Ludger Rosin; W. Stegink; Gerhard Steinbeck; Panos Vardas; Alphons Vincent; Maureen Walter;

Affiliations : Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de

Journal : Eurpopace   (2011)

Related Links: Pubmed | Publisher website

n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion

Authors : Savina Nodari, MD; Marco Triggiani, CirculationMD; Umberto Campia, MD; Alessandra Manerba, MD; Giuseppe Milesi, MD; Bruno M. Cesana, MD; Mihai Gheorghiade, MD;

Affiliations : Correspondence to Livio Dei Cas, MD, Professor of Cardiology, Director, Department of Experimental and Applied Medicine, Section of Cardiovascular Diseases, University of Brescia Medical School, P. le Spedali Civili, 1–25123 Brescia, Italy. E-mail deicas@med.unibs.it

Journal : Circulation   (2011)

Related Links: Pubmed | Publisher website

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.

Authors : Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M;

Affiliations : Correspondence to Livio Dei Cas, MD, Professor of Cardiology, Director, Department of Experimental and Applied Medicine, Section of Cardiovascular Diseases, University of Brescia Medical School, P. le Spedali Civili, 1–25123 Brescia, Italy. E-mail deicas@med.unibs.it

Journal : Circulation   (2011)

Related Links: Pubmed | Publisher website

Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial

Authors :

Affiliations : Correspondence to Dr Roberto Latini, Department of Cardiovascular Research, Istituto ‘Mario Negri’, via Giuseppe La Masa 19, 20156 Milan, Italy; roberto.latini@marionegri.it

Journal : Original article   (2010)

Related Links: Pubmed | Publisher website

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Authors :

Affiliations : University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Institute for Biomedical Research, 1st Floor, Room 136, Birmingham B15 2TT, UK University Hospital Münster, Münster, Germany AFNET, Germany CHU de Nancy, Nancy, France Duke University School of Medicine, Durham, NC, USA Fondazione Cardiocentro Ticino, Lugano, Switzerland St. Jude Medical, St. Paul, MN, USA Department of Cardiology, University of Leiden Medical Center, Leiden, NL, The Netherlands Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden St. Antonius Hospital, Nieuwegein, The Netherlands University of Bologna, Bologna, Italy Odense University Hospital, Odense, Denmark Meda Pharma SAS, Paris, France University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany The Johns Hopkins Hospital, Baltimore, MD, USA University of Oxford, Oxford, UK University Hospital Maastricht, Maastricht, The Netherlands Daiichi Sankyo Europe GmbH, Munich, Germany University Duisburg-Essen, Essen, Germany Lankenau Institute for Medical Research, Wynnewood, PA, USA CRI—The Clinical Research Institute, Munich, Germany Ludwig Maximilian University, Munich, Germany University of Calgary/Libin, Calgary, Alberta, Canada Garibaldi-Nesima Hospital, Catania, Italy Bristol-Myers Squibb, Munich, Germany University Hospital Zurich, Zurich, Switzerland Faculté de Médecine Pitié-Salpêtrière, Paris, France Charité Berlin, Berlin, Germany University Hospital Gasthuisberg, Leuven, Belgium Hôpital Cardologique du Haut-Lévêque and the Université Victor Segalen Bordeaux II, Bordeaux, France University of Lausanne, Lausanne, Switzerland Institute for Clinical and Experimental Medicine, Prague, Czech Republic Klinik St. Georg, Hanseatisches Herzzentrum, Hamburg, Germany Isar Herzzentrum, Munich, Germany Medtronic International Trading Sàrl, Tolochenaz, Switzerland Hospital Clínic, University of Barcelona, Barcelona, Spain Pfizer Deutschland GmbH, Berlin, Germany Aarhus University Hospital, Aarhus, Denmark Städtisches Klinikum Brandenburg, Brandenburg, Germany Hacettepe University Faculty of Medicine, Ankara, Turkey Medizinische Universität Graz, Graz, Austria University of Belgrade, Belgrade, Serbia TU Dresden, Dresden, Germany Columbia University Medical Center, New York, NY, USA Bristol-Myers Squibb, Rueil-Malmaison, Paris, France Bayer Vital GmbH, Leverkusen, Germany St. Jude Medical, Zaventem, Belgium Boston Scientific, St. Paul, MN, USA Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany Institute of Cardiology, Warsaw, Poland Ettore Sansavini Health Science Foundation, Cotignola, Italy Ospedale dell'Angelo, Mestre-Venice, Venice, Italy Bayer Pharma AG, Berlin, Germany University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Sanofi Aventis Deutschland GmbH, Berlin, Germany University College Hospital, London, UK University Heart Center Hamburg, Hamburg, Germany St. George's Hospital Medical School, London, UK

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Pulmonary vein isolation in patients with Brugada syndrome and atrial fibrillation: a 2-year follow-up

Authors :

Affiliations : Heart Rhythm Management Centre, UZ Brussel-VUB, Laarbeeklaan 101, 1090 Brussels, Belgium

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

Authors :

Affiliations : Department of Cardiology, Thorax Institute, Hospital Clínic de Barcelona, University of Barcelona, C/ Villarroel 170, 08036 Barcelona, Spain Heart Center, University of Leipzig, Leipzig, Germany Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Cotignola, Italy Department of Cardiology, Heraklion University Hospital, Crete, Greece Service De Cardiologie, Hopital Charles Nicolle, Rouen Cedex, France Ospedale Maggiore Di Crema, Crema, Italy Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, France Department of Cardiology, Silesian Academy of Medicine, Zabrze, Poland Department of Cardiology, Institute for Clinical and Experimental Medicine IKEM, Prague, Czech Republic Department of Cardiology, Isar Heart Center, Munich, Germany Cliniques du Sud Luxembourg – Vivalia, Arlon, Belgium Hospital Clinico Universitario San Carlos, Madrid, Spain Aalborg Hospital, Aalborg, Denmark Department of Internal Cardology, Faculty Hospital Olomouc, Olomouc, Czech Republic Henry Dunant Hospital/Errikos Dynan Hospital, Athens, Greece Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands

Journal : N/A   (2012)

Related Links: Pubmed | Publisher website